Prognostic factors in advanced Hodgkin's disease--can they guide therapeutic decisions?

One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin Lymphoma.

Hematological oncology·2024

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.

British journal of haematology·2023

Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma.

Annals of hematology·2021

Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome.

The British journal of dermatology·2021

Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2020

Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen.

Scientific reports·2019

Treatment Decisions in Multiple Myeloma.

The New England journal of medicine·2026

Outbreak of Severe Methemoglobinemia during Maritime Migration.

The New England journal of medicine·2026

Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

The New England journal of medicine·2026

Tozorakimab to Prevent COPD Exacerbations.

The New England journal of medicine·2026

Risk factors and nomogram for predicting central lymph node metastasis in papillary thyroid carcinoma based on gasless transaxillary endoscopic thyroidectomy.

Gland surgery·2026

miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells.

Translational cancer research·2026

Preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma: a nomogram integrating dual-plane ultrasound-based radiomics and clinical features.

Gland surgery·2026

How cholecystectomy and gastrectomy contribute to pancreatic cancer development: a review.

Annals of medicine and surgery (2012)·2026

Development and internal validation of dual overall and cancer-specific survival nomograms for primary spinal and sacropelvic Ewing sarcoma: a population-based study of 346 patients.

Translational cancer research·2026

Development of m6A-related prognostic models for survival in lung squamous cell carcinoma with different PD-L1 expression levels.

Translational cancer research·2026

Related Experiment Videos

Prognostic factors in advanced Hodgkin's disease--can they guide therapeutic decisions?

Related Concept Videos

One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin Lymphoma.

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.

Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma.

Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome.

Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen.

Treatment Decisions in Multiple Myeloma.

Outbreak of Severe Methemoglobinemia during Maritime Migration.

Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

Tozorakimab to Prevent COPD Exacerbations.

Risk factors and nomogram for predicting central lymph node metastasis in papillary thyroid carcinoma based on gasless transaxillary endoscopic thyroidectomy.

miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells.

Preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma: a nomogram integrating dual-plane ultrasound-based radiomics and clinical features.

How cholecystectomy and gastrectomy contribute to pancreatic cancer development: a review.

Development and internal validation of dual overall and cancer-specific survival nomograms for primary spinal and sacropelvic Ewing sarcoma: a population-based study of 346 patients.

Development of m6A-related prognostic models for survival in lung squamous cell carcinoma with different PD-L1 expression levels.

Related Experiment Videos

Prognostic factors in advanced Hodgkin's disease--can they guide therapeutic decisions?

Related Concept Videos

Related Articles